Povidone-Iodine is an antiseptic used to kill bacteria and germs on the skin before surgery or to prevent infection in minor cuts, scrapes, and wounds.[2] Betadine is currently approved and in use across 31 indications[4].[1]
Betadine is one of 486 small molecule programs targeting Corneal Ulcer. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
2828 competitors in Breast Cancer
Betadine
Megace
Lexiscan
Adenocard
Sporanox
Zoladex
Neoadjuvant Therapy
Neoadjuvant Treatment
Bisphosphonate
Naltrexone/bupropion
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Nov 29, 1985
E-Z SCRUB 201
NDA NDA019240
Dec 17, 1986
BETADINE
NDA NDA018634
Jan 7, 1987
E-Z SCRUB 241
NDA NDA019476
Mar 31, 1989
POVIDONE IODINE
NDA NDA019522
Jul 25, 1989
E-Z PREP
NDA NDA019382
Sources
Details